These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11245352)

  • 21. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy.
    Hammerman C; Kaplan M; Vreman HJ; Stevenson DK
    Biol Neonate; 1996; 70(2):69-74. PubMed ID: 8864425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility.
    Kohan AI; Niborski RC; Rey JA; Amerise G; Vázquez MI; Zani N; Calahonra R; Binaghi A; Sánchez Avalos J
    Vox Sang; 1994; 67(2):195-8. PubMed ID: 7801611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
    Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
    J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose intravenous immunoglobulin in the management of immune hemolysis in patients with thalassemic disease: factors which determine refractoriness.
    Wanachiwanawin W; Pootrakul P; Fucharoen S; Piankijagum A
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):397-401. PubMed ID: 1726338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable Clinical Presentations of ABO Incompatibility in Dizygotic Twins.
    Mundy CA; Bhatia J
    Neonatal Netw; 2015; 34(6):317-9. PubMed ID: 26803011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of intensive blue double-lamp phototherapy in the treatment of ABO incompatibility and idiopathic severe hemolytic jaundice].
    Amato M; Von Muralt G
    Pediatr Med Chir; 1984; 6(1):95-8. PubMed ID: 6531243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
    Huang WM; Chen HW; Li N; Yang M; Jiao PY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of phototherapy in the treatment of jaundice caused by ABO and Rh blood group incompatibility].
    Godula-Stuglik U; Ulman-Doniec I; Doniec Z; Grzybowski A
    Acta Haematol Pol; 1988; 19(1-2):86-91. PubMed ID: 3149117
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012.
    Berg R; Shebl A; Kimber MC; Abraham M; Schreiber GB
    Transfusion; 2015 Jul; 55 Suppl 2():S36-46. PubMed ID: 26174896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phototherapy in Rh incompatibility hyperbilirubinaemia.
    Bajpai PC; Tripathi TK; Singh D; Kapoor CL
    Indian J Med Res; 1973 Feb; 61(2):221-31. PubMed ID: 4202379
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
    Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phototherapy and infusion therapy of hemolytic diseases of the newborn due to rhesus factor incompatibility].
    Leshkevich IA; Dobronravov AV; Kalashnikova TI; Semenkova AS
    Vopr Okhr Materin Det; 1979 Jun; 24(6):15-9. PubMed ID: 112781
    [No Abstract]   [Full Text] [Related]  

  • 35. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin for hemolytic jaundice in Japan: A retrospective survey.
    Ono H; Kakiuchi S; Kusuda S
    Pediatr Int; 2023; 65(1):e15702. PubMed ID: 38037498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 40. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
    Keir AK; Dunn M; Callum J
    J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.